RESTORES Trial: RESToration Of Rehabilitative Function With Epidural Spinal Stimulation (RS-01)
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT05644171 |
Recruitment Status :
Recruiting
First Posted : December 9, 2022
Last Update Posted : March 14, 2023
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Chronic Spinal Cord Injury | Device: RESToration Of Rehabilitative function with Epidural spinal Stimulation | Not Applicable |
Study Type : | Interventional (Clinical Trial) |
Estimated Enrollment : | 3 participants |
Allocation: | N/A |
Intervention Model: | Single Group Assignment |
Masking: | None (Open Label) |
Primary Purpose: | Treatment |
Official Title: | RESTORES Trial: RESToration Of Rehabilitative Function With Epidural Spinal Stimulation |
Actual Study Start Date : | December 19, 2022 |
Estimated Primary Completion Date : | May 30, 2024 |
Estimated Study Completion Date : | August 30, 2024 |

Arm | Intervention/treatment |
---|---|
Patients with motor complete chronic spinal cord injury |
Device: RESToration Of Rehabilitative function with Epidural spinal Stimulation
Three patients with chronic motor SCI will be recruited in total for this study. The recruited patients will not be randomized nor blinded due to the nature of this study. Pre-op rehabilitation session will take place over 4 weeks. 1 month post-surgical implants, patients will undergo 24 weeks of rehabilitation. The training sessions may continue to take place after the stipulated 24 weeks as long the electrode remains implanted, and the patient is available. |
- Number of participants with treatment-related adverse events assessed by CTCAE v5.0 [ Time Frame: 6 months ]The adverse events in patient's with proposed surgical implantation and robotic neuro-rehabilitation during the course of study will be assessed. Particularly, during the first 6 months of the study and post implantation.
- Assessing the improvement in motor outcomes post surgical implantation [ Time Frame: 2 years ]
Volitional control including independent locomotion with epidural spinal stimulation and robotic neuro-rehabilitation will be assessed to check for improvement in motor functions.
This assessment will be done during rehabilitation session where the post-surgical movement results will be compared against the pre-surgical results for better understanding and study.
- Assessing autonomic function post surgical implantation [ Time Frame: 2 years ]The improvement in hemodynamic, bowel and bladder control with epidural spinal stimulation and robotic neuro-rehabilitation will be assessed continuously post surgical implantation

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 21 Years and older (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
⦁ Inclusion Criteria
For inclusion in the study, the potential patient has to fulfil all of the following criteria:
- 21 years old and older
- Chronic (greater than one year) motor complete (AIS classification A or B) SCI
- Spinal injury between the levels of Thoracic 2 (T2) to Lumbar 1 (L1)
- Segmental reflexes that remain functional below the level of lesion
-
Able to perform the perioperative rehabilitation program as judged by the research team
- Exclusion Criteria
Potential patients will be excluded from the trial if they fulfil any of the following criteria:
- Significant medical co-morbidities that would significantly increase the risk of the operation
- Severe dysautonomia with systolic blood pressure fluctuation less than 50 or more than 200mmHg on tilt table testing
- Painful musculoskeletal dysfunction, contractures, unhealed fractures, pressure sores, severe spasticity, and osteoporosis
- Significant psychological issues or ongoing drug abuse
- Pregnancy and lactating patients
- Progressive spinal cord disease

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT05644171
Contact: Kai Rui Wan, MBBS | 63577538 | wan.kai.rui@singhealth.com |
Singapore | |
National Neuroscience Institute | Recruiting |
Singapore, Singapore | |
Contact: Kai Rui Wan, MBBS 63577538 wan.kai.rui@singhealth.com |
Responsible Party: | National Neuroscience Institute |
ClinicalTrials.gov Identifier: | NCT05644171 |
Other Study ID Numbers: |
RS-01 |
First Posted: | December 9, 2022 Key Record Dates |
Last Update Posted: | March 14, 2023 |
Last Verified: | March 2023 |
Studies a U.S. FDA-regulated Drug Product: | No |
Studies a U.S. FDA-regulated Device Product: | No |
Spinal cord injury Epidural spinal stimulation Implantation |
Spinal Cord Injuries Spinal Cord Diseases Central Nervous System Diseases |
Nervous System Diseases Trauma, Nervous System Wounds and Injuries |